Mayne Pharma Group Ltd
ASX:MYX
Mayne Pharma Group Ltd
Pre-Tax Income
Mayne Pharma Group Ltd
Pre-Tax Income Peer Comparison
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Mayne Pharma Group Ltd
ASX:MYX
|
Pre-Tax Income
-AU$269.7m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
Recce Pharmaceuticals Ltd
ASX:RCE
|
Pre-Tax Income
-AU$11.3m
|
CAGR 3-Years
5%
|
CAGR 5-Years
-46%
|
CAGR 10-Years
N/A
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Pre-Tax Income
AU$205.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
132%
|
CAGR 10-Years
N/A
|
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
Pre-Tax Income
-AU$14.6m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-24%
|
|
Probiotec Ltd
ASX:PBP
|
Pre-Tax Income
AU$13m
|
CAGR 3-Years
15%
|
CAGR 5-Years
19%
|
CAGR 10-Years
19%
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Pre-Tax Income
-AU$24.5m
|
CAGR 3-Years
-52%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Mayne Pharma Group Ltd's Pre-Tax Income?
Pre-Tax Income
-269.7m
AUD
Based on the financial report for Jun 30, 2023, Mayne Pharma Group Ltd's Pre-Tax Income amounts to -269.7m AUD.
What is Mayne Pharma Group Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
-10%
Over the last year, the Pre-Tax Income growth was -85%. The average annual Pre-Tax Income growth rates for Mayne Pharma Group Ltd have been -26% over the past three years , -10% over the past five years .